Home
Duchenne
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Our Tools
Exon Check Tool
Clinical Trials
Active Studies
Trial Statistics
Trials Map
Pipeline
Search
About Us
Contact
APPs
Privacy Policy
type here...
Search
Instagram
Facebook
Twitter
Bluesky
Home
Duchenne
Duchenne MD
What is Duchenne?
Genetic Causes
Creatine Kinase (CK)
Genetic Testing
Prenatal Testing
Becker MD
DMD vs BMD
NSAA Assessment
Genetic
Genetic Counseling
Dystrophin Gene
Genetic Variants
Exon Deletion
Duchenne Carriers
Nucleotides in DMD
Isoforms in DMD
What is Exon Skipping
Care Guidelines
Newly Diagnosed
Neuromuscular Team
Respiratory Devices
BiPAP Machine
Ankle Foot Orthosis
Rhabdomyolysis
Power Wheelchair
Traveling with DMD
Health Guidelines
Psychological Support in DMD
Nutrition in DMD
Nutraceuticals
Respiratory Health
Dental Health
Surgery & Anesthesia
Swallowing Difficulty
Steroids (Cortisone)
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Our Tools
Exon Check Tool
Clinical Trials
Active Studies
Trial Statistics
Trials Map
Pipeline
WhatsAPP
Home
Tags
Solid Biosciences
Solid Biosciences
Press Releases
European Commission Grants Orphan Drug Designation to SGT-003 for Duchenne Muscular Dystrophy
Editorials
Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy
Press Releases
SGT-003 Gene Therapy: INSPIRE DUCHENNE Phase 3 Study Begins
Press Releases
Solid Biosciences Aligns With FDA on SGT-003 Phase 3 Trial Design for Duchenne Muscular Dystrophy Gene Therapy
Editorials
Compared to Its Million-Dollar Price Tag, How Much Does Elevidys Gene Therapy Improve the Condition of Children With DMD?
Press Releases
Solid Biosciences Announces 2026 Outlook for Clinical Trials of Duchenne Gene Therapy SGT-003
Press Releases
Solid Biosciences Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
Press Releases
Solid Biosciences Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
Research
Solid Biosciences Initiates Phase 3 Clinical Trial of SGT-003 Gene Therapy (IMPACT DUCHENNE) in Ambulant Males
1
2
Page 1 of 2
Popular
Frequently Asked Questions About Elevidys Used for DMD
Can Ekinci
-
August 21, 2026
Must Read
Editorials
CRISPR GuideX Tool: hfCas12Max in CRISPR-Based Therapeutics
Care Guidelines
Breathing Exercises in Duchenne Muscular Dystrophy: Respiratory Therapy, Pulmonary Care & Lung Support
Research
BioMarin Launches BMN 351 Exon 51 Skipping Therapy Phase 2 Clinical Trial for Duchenne Muscular Dystrophy
EN
AR
ZH
FR
DE
HI
RU
PT
ES
TR